Healthcare Dive4d
A new, non-opioid pain drug is here. Getting it to patients could be agony.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
Healio5d
Q&A: Pain management possible for patients with drug allergies
Patients who experience musculoskeletal pain have many pharmaceutical options for relief — unless they also suffer from ...
The Taipei Times14d
US FDA approves new pain drug
Vertex’s pill, called Journavx, received US Food and Drug Administration clearance to treat moderate to severe acute pain, a statement said on Thursday. The wholesale acquisition cost for the ...
WUNC14d
This new pain drug is being touted as a non-addictive alternative to opioids
A new kind of pain medication has been approved for sale ... You know, she's chief of pain management at Newton-Wellesley Hospital outside Boston. And, you know, she says it's a difficult ...
WROC-TV14d
FDA approves opiate-alternative acute pain management drug, local experts share their thoughts
ROCHESTER, N.Y. (WROC) – On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare providers address pain management. Suzetrigine, ...
healthday15d
FDA Approves First New Non-Opioid Pain Pill in Decades
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin ...
Putnam Daily Voice15d
FDA Approves First Non-Opioid Pain Drug In 20+ Years—Developed By Boston Drugmaker
"Today's approval is an important public health milestone in acute pain management,” said Dr. Jacqueline Corrigan-Curay, acting director of the FDA's Center for Drug Evaluation and Research. "A new ...
Euronews15d
US drug regulator approves first new type of pain pill in more than 20 years
The US medicines regulator approved a new type of pain pill that aims to eliminate the risks of addiction and overdose associated with medications that launched the US into an opioid epidemic more ...
AFP15d
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
JOURNAVX (suzetrigine) is a first-in-class, oral, non-opioid, highly selective pain signal inhibitor that is selective for NaV1.8 relative to other NaV channels.
Business Insider15d
FDA Approves Vertex Pharma's JOURNAVX As The First Drug In A New Class Of Non-Opioid Pain Medicines
The drug, which will be marketed under the brand name JOURNAVX, is the first and only approved non-opioid oral pain signal inhibitor and the first new class of pain medicine approved in more than ...
Medscape15d
FDA OKs First-In-Class Nonopioid Pain Med Suzetrigine
The US Food and Drug Administration (FDA) has approved suzetrigine 50 mg tablets (Journavx, Vertex Pharmaceuticals), a first-in-class nonopioid analgesic for treatment of adults with moderate-to ...
ConsumerAffairs15d
A new non-opioid pain medication wins Food and Drug Administration approval
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction of a first-in-class non ... as a reliable pain management solution.